NIH-funded research U01 cooperative agreement

Gateway Program for Vector-Borne Diseases in the Southeast

Official title: CK22-005 - CDC Southeastern Center of Excellence in Vector-Borne Diseases: Gateway Program

Funded at University of Florida · NIH-11510001 · Data updated 2026-11-12

A national network led by the University of Florida is renewing funding to strengthen surveillance, training, and coordinated responses to vector-borne diseases across the Southeast and Puerto Rico.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startJuly 1, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$2,000,000
NIH project number5U01CK000662-05
Project IDNIH-11510001 on NIH RePORTER

Who could benefit from this research

Could help

Not currently a clinical trial; benefits are aimed at communities through improved disease surveillance and response.

Less likely to help

Direct patient benefits may be indirect or limited to communities rather than individual participants.

What this research studies

This grant supports an integrated academic network that brings together universities, public health agencies, and local vector-control programs to improve detection and response to vector-borne diseases. It combines basic vector biology with applied epidemiology and public health surveillance, and it includes an online and internship-based training component to grow the workforce. The program aims to create a practical, evidence-based surveillance and response framework that can be implemented by health departments and partner organizations. Through collaboration and ongoing training, it seeks to enhance readiness to detect and respond to VBDs across the region.

Why it matters

Potential benefit: Strengthened public health capacity to prevent and control vector-borne diseases in the Southeastern U.S. and Puerto Rico.

How similar studies have gone: The network structure and training components build on established collaborations and have a track record of enhancing public health readiness in vector-borne disease control.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Dinglasan, Rhoel David Ramos — University of Florida
  • Study coordinator: Dinglasan, Rhoel David Ramos

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.